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Purpose: To determine whether quantitation of T2 is sufficiently repeatable and sensitive to detect clinically relevant
oxygenation levels in head and neck squamous cell carcinoma (HNSCC) at 3T.
Materials and Methods: Ten patients with newly diagnosed locally advanced HNSCC underwent two magnetic resonance
imaging (MRI) scans between 24 and 168 hours apart prior to chemoradiotherapy treatment. A multiple gradient echo
sequence was used to calculate T2 maps. A quadratic function was used to model the blood transverse relaxation rate as a func-
tion of blood oxygenation. A set of published coefficients measured at 3T were incorporated to account for tissue hematocrit
levels and used to plot the dependence of fractional blood oxygenation (Y) on T2 values, together with the corresponding
repeatability range. Repeatability of T2 using Bland–Altman analysis, and calculation of limits of agreement (LoA), was used to
assess the sensitivity, defined as the minimum difference in fractional blood oxygenation that can be confidently detected.
Results: T2 LoA for 22 outlined tumor volumes were 13%. The T

2 dependence of fractional blood oxygenation increases
monotonically, resulting in increasing sensitivity of the method with increasing blood oxygenation. For fractional blood
oxygenation values above 0.11, changes in T2 were sufficient to detect differences in blood oxygenation greater than
10% (DT2 > LoA for DY>0.1).
Conclusion: Quantitation of T2 at 3T can detect clinically relevant changes in tumor oxygenation within a wide range of
blood volumes and oxygen tensions, including levels reported in HNSCC.
J. MAGN. RESON. IMAGING 2016;44:72–80.
Tissue oxygenation is an important parameter of the tumormicroenvironment that influences both proliferation and
angiogenesis.1,2 The presence of hypoxic regions within tumors
is considered an important cause of treatment failure affecting
both radiotherapy and chemotherapy, and adversely affects the
prognosis of head and neck squamous cell carcinoma
(HNSCC).3–5 Noninvasive methods to rapidly quantify the spa-
tial distribution and extent of hypoxia within an individual
tumor are thus highly desirable in clinical practice to allow mod-
ification of treatment strategies in this poorer prognosis group.
Magnetic resonance imaging (MRI) measurements of
the transverse relaxation time (T 2 ) have been proposed as
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imaging biomarkers of tissue oxygenation status in both pre-
clinical and clinical settings.3,4,6,7 Paramagnetic deoxyhemo-
globin increases the apparent MRI transverse relaxation rate
R2 (51/T

2 ) of water in blood and surrounding tissues,
which provides the opportunity to image tissue oxygenation
at high spatial resolution. The T 2 of the vascular space is
dependent on fractional blood oxygenation (Y), and can be
described by a quadratic function of hematocrit levels (Hct)
and magnetic field strength (B0).
8,9 Changes in R2 are used
to study brain activity associated with modulated regional
brain perfusion (the blood oxygen level dependent or
BOLD effect).10 However, the strength of the correlation
between tissue R2 and tissue oxygen partial pressure (pO2),
measured using oxygen electrodes, and immunohistochemi-
cal detection of the hypoxia marker pimonidazole, has been
reported to be only weak to moderate.11–13 Consequently,
quantitative measurements of tissue oxygenation using
BOLD have yet to be established.14
BOLD measurements can also be performed in combi-
nation with hyperoxic gas breathing, whereby the oxy/
deoxygenated hemoglobin ratio is altered. The magnitude of
changes in BOLD measurements within tumors, on breath-
ing hyperoxic gas relative to air, have been shown to relate
to the tumor hypoxic fraction as determined by pimonida-
zole labelling.15 An increase in T 2 was found to correlate
with inhalation of higher percentages of oxygen in preclini-
cal studies, but the magnitude of signal changes was not
proportional to the absolute measured tissue oxygenation.16
Preclinical and clinical studies in prostate, cervix, and head
and neck cancers have consistently reported increases in
tumor tissue T 2 in response to hyperoxic gas challenge.
17–20
In contrast, studies in breast cancer have shown differing
results, as tumors were found to exhibit T 2 decreases following
hyperoxic challenge but with relatively large magnitude varia-
tion in the magnitude of T 2 changes.
21 This discrepancy is
thought to relate to differences in tumor biology across histol-
ogies.15,21,22 Such discordant results may be explained by T 2 -
weighted signal dependence on physiological factors, including
the hematocrit, blood volume (BV), vessel caliber,23,24 and the
intermittent tumor vessel blood flow.16,25 Therefore, the rela-
tionship of baseline tumor tissue T 2 to tumor hypoxia varies
according to the nature of the tumor vasculature and its host
hematological status. It therefore should not be surprising that
tumor T 2 and its response to various tumor challenges (treat-
ment, hyperoxia) varies according to tumor type.
In addition to the tumor vascular microenvironment,
quantitation of T 2 is also dependent on physiochemical and
methodological parameters.14,26,27 Macroscopic magnetic
field homogeneity resulting from the iterative shimming
process affects the repeatability of T 2 measurements. The
measured T 2 value within a voxel is a composite of spin
relaxation rates within the intra- and extravascular tissue
spaces, a consequence of the scanning spatial resolution.
Spin relaxation in the extravascular space has a much weaker
and variable dependency on blood oxygenation than that for
the intravascular space within a tumor.10,26
Hypoxia is a common and well-recognized cause of
radioresistance in HNSCC, and therefore MRI-based meas-
urements of oxygenation in this region are of significant inter-
est.3–5 In this study we evaluated whether T 2 measurements
are sufficiently sensitive to detect clinically relevant oxygen-
ation levels in HNSCC at 3T, acknowledging the influence of
measurement repeatability, blood volume, and hematocrit.
Materials and Methods
Patients and MRI
MR images were acquired in two scanning sessions, between 24
and 168 hours apart, in 10 patients (nine male, one female) with
newly diagnosed locally advanced HNSCC, prior to their treat-
ment. A summary of the patient characteristics is presented in
Table 1. The median age of the patients was 57 years (range: 44–
64 years). Written informed consent was obtained from all patients
in this study, which was approved by the Institutional Research
Review Board (CCR 3970) and the NHS Research Ethics Com-
mittee (REC number 13/LO/0628).
MRI was performed at 3T (MAGNETOM Skyra, Siemens
Healthcare, Erlangen, Germany) using a dedicated 20-channel head
and neck coil. Patients were aligned in a supine position with slight
neck extension using a standard headrest and lateral cushions for
improved stabilization. Anatomical coronal T2-weighted images (TSE,
TE/TR5 76/5000 msec, field of view [FOV]5 250 3 250 mm2,
4 mm slice thickness) were obtained first in order to assess the extent of
the disease and aid axial sequence planning. Subsequently, T2-weighted
(TSE, TE/TR5 84/4560 msec, FOV5 2403 240 mm2, 2.5 mm slice
thickness) and T 2 images were acquired over the volume of interest
(VOI) identified by a clinician (L.W. or K.W.). T 2 was measured using
a 2D gradient echo sequence with six echo times (flip angle [FA]5 248,
TE5 4.92 to 29.52 msec in increments of 4.92 msec, TR5 350 msec,
FOV5 240 3 240 mm2, 2.5 mm slice thickness, acquisition matrix:
2563 256, BW5435 Hz). Echoes were acquired with the same gradi-
ent polarity with in-phase fat and water signal. No signal normalization
or filtering was used. All the imaging data were anonymized, coded,
and exported to a dedicated research PACS database system (XNAT).28
Images acquired from the first MRI session were used as a guide to rep-
licate patient positioning and VOI identification in the second session.
A blood sample was taken for a full blood count prior to each MRI
scans to determine blood hematocrit.
MRI Data Analysis and VOI Definition
Paired image datasets were retrieved for image coregistration, VOI
definition, and image processing. Signal changes on the multiple
gradient echo images were used to calculate 3D T 2 relaxivity
maps. Data processing was performed using in-house MatLab soft-
ware (MathWorks, Natick, MA). Signal intensity decay, measured
for increasing echo times, was fitted on a voxel-by-voxel basis to a
monoexponential model using a least-squares fit method. No data
truncation or filtering was used. Calculated T 2 maps were exported
in the DICOM format allowing further analysis with a radiother-
apy treatment planning system (TPS).
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VOIs, including primary and nodal tumor sites, were man-
ually delineated by radiologists (A.M.R. and D.M.K., each having
more than 10 years of experience) using the Pinnacle3 TPS (Phi-
lips Healthcare, Best, Netherlands). Axial images and T 2 maps
from both MRI sessions were coregistered using operator-assisted
rigid body algorithms. T 2 images with significantly varying neck
flexion or translation of tumor volume were identified and the cor-
egistration manually corrected. For such cases primary tumor and
involved lymph nodes were coregistered independently to compen-
sate for interscan anatomical and positional variation. T 2 values
for respective VOIs were exported from the TPS and used for sta-
tistical evaluation.
Statistical Assessment of Repeatability
Tissue T 2 values were analyzed using boxplots and T

2 difference
maps were generated for each VOI to investigate the data distribu-
tion and spatial repeatability. Median T 2 values were calculated for
each VOI and used to assess the quantitative repeatability, to
account for a skewed parameter distribution previously described
in the literature.15,19 First, the Shapiro-Wilk test was used to ascer-
tain normality of the sample T 2 distribution. Second, the Wil-
coxon signed rank test was used to compare T 2 distributions from
each session to check whether the observed interscan variability
could be attributed to measurement error. The Bland–Altman
method was used to plot the T 2 differences between two scan ses-
sions against the mean value of median VOI T 2 for both ses-
sions.29 Finally, the coefficient of variation (CV) and limits of
agreement (LoA, average difference6 1.96 standard deviation of
the difference) were calculated. The potential influence of both the
tumor volume and the duration between scans on repeatability was
investigated. Kendall’s tau (s) was used to test for correlation
between median T 2 changes between sessions and VOI volumes,
and also between T 2 changes and the interval between scans.
SIMULATION OF BLOOD OXYGENATION DEPENDENCE OF
T2 . A quadratic model was used to describe the blood transverse
relaxation rate R2 as a function of fractional blood oxygenation
(Y)8,9:
R25A
1Bð12YÞ1Cð1-YÞ2 (1)
where A*, B*, and C* are empirically derived coefficients depend-
ent on B0 and Hct.
Coefficients A*, B*, C* previously measured empirically for
Hct in the range 0.21–0.57 at 3T9 were used to obtain R2(Hct,Y)
values in the full range of blood oxygenation fractions.
In our simulations, a “tissue hematocrit” (Htiss) was used,
incorporating the BV fraction and a vascular factor (fvas5 0.85) to
account for differences between erythrocyte concentration in large
vessels and the tissue capillary network24,26:
Htiss5Hct3BV3f vas (2)
The initial R2(Y) values for Hct in the range 0.21–0.57 were
linearly extrapolated to calculate a new set of R2 values at the tissue
hematocrit levels. Five blood volume fractions in the range 1–
30 ml/100g were considered, including values typical for muscle
(BV5 1 ml/100g30, HNSCC (BV5 5 ml/100g31, and highly vas-
cular tumors (BV> 10 ml/100g24. Equation (1) was used to calcu-
late sets of BV-specific coefficients A*, B*, and C* and to plot the
dependence of blood oxygen saturation on T 2 values.
A simulated y-intercept value for BV5 5 mL/100g was sub-
tracted to derive and plot the relative T 2 dependence of fractional
blood oxygenation and pO2 together with corresponding 95% lim-
its of agreement. Relative, rather than absolute, T 2 values were
used in order to assess the minimum difference in fractional blood
oxygenation that can be reliably detected (T 2 changes greater than
limits of agreement) and to recognize the effect of tissue-specific
extravascular spin relaxation. Finally, the Hill equation (Hill’s
TABLE 1. Summary of Patient Characteristics
Patient
no.
Age
(years)
Gender Site Stage HPV
status
Interval between
scans (hours)
Hct
MRI1 MRI2
1 57 M Oropharynx T3N2bM0 1ve 36 0.300 0.343
2 51 M Oropharynx T2N2aM0 1ve 48 0.417 0.411
3 50 M Hypopharynx T3N2bM0 2ve 24 0.431 0.418
4 63 M Oropharynx T4N0M0 1ve 144 0.459 0.441
5 58 M Oropharynx T2N2cM0 1ve 48 0.283 0.354
6 64 M Supraglottis T2N2bM0 2ve 144 0.441 0.431
7 64 M Oropharynx T2N2c M0 1ve 168 0.437 0.431
8 64 M Supraglottis T3N2cM0 2ve 96 0.364 0.400
9 44 M Oropharynx T1N2bM0 Unk 168 0.397 0.398
10 51 F Oropharynx T3N2cM0 1ve 72 0.389 0.402
*Unk5Unknown human papilloma virus (HPV) status.
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coefficient: 2.26, t5 378C, pH: 7.4) was used to identify the clini-
cally relevant region of hypoxia (pO2< 20 mmHg, Y5 0.32).
6,32
RESULTS
Repeatability
The median time interval between two scans was 84 hours
(range: 24–168 hours). For all patients there was no signifi-
cant difference (P5 0.57) in the group mean Hct across the
two MRI sessions, with a respective mean value of 0.4
(range: 0.283–0.459). Anatomical image coregistration
revealed varying degrees of differences in patient neck flex-
ion between the MRI sessions, despite having attempted to
replicate patient positioning at each visit. However, it was
possible to compensate for these differences in patient posi-
tioning by independent regional coregistration for primary
and nodal VOIs.
In total, 22 VOIs were identified and outlined. An
example of a VOI overlaid on a T2-weighted image is pre-
sented in Fig. 1A. One primary tumor and one lymph node
(Table 2: patients 1, 10) were excluded from analysis due to
inadequate VOI coverage resulting from differences in
patient positioning between sessions and/or significant inter-
nal motion between T2-weighted and T

2 examinations.
Representative parametric T 2 maps, with corresponding dif-
ferences in T 2 between the visits on a per-voxel basis, and
VOI boxplots, are shown in Fig. 1. Table 2 summarizes the
measured VOI parameters, including location, volume, T 2
values, and differences between the two MR examinations.
The mean T 2 values significantly (P< 0.01) differed
between nodes (23.6 msec) and primary tumor sites (18.7
msec). The distribution of intra-VOI T 2 values was posi-
tively skewed. An example of the spatial distribution of dif-
ferences between the relaxation times in two MR
FIGURE 1: A: T2-weighted image for a 50-year-old stage IV HNSCC patient (patient 3) with outlined primary VOI (red). B: T

2 para-
metric maps calculated for visit 1 (three representative slices at the center of the tumor). C: Boxplots showing distributions of T2
measured in primary tumor VOI in both visits and differences in T 2 between the visits. D: Differences in T

2 between the visits on
a per-voxel basis.
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examinations (DT 2 ) is presented in Fig. 1D. Subregions of
uniformly increased or decreased T 2 can be observed within
analyzed VOIs.
The distribution of T 2 for all patient VOIs did not
differ from normality (primary tumors: P5 0.48, lymph
nodes: 0.61) and the population mean values did not differ
between the two scan sessions (primary tumors: P5 0.32,
lymph nodes: P5 0.64). A Bland–Altman plot showing T 2
difference between the two scans (MR2-MR1) against the
mean value of VOI median T 2 for both sessions is shown
in Fig. 2. The coefficient of variation and limits of agree-
ment were 6.9 and 13%, respectively. There was a weak
negative and nonsignificant correlation between median T 2
differences and the VOI volumes (s5 –0.14, P5 0.11), and
also between median T 2 differences and interval between
scans (s5 –0.12, P5 0.48).
Simulations
The average tissue hematocrit levels, Htiss, were calculated
using a mean of patient Hct values, and for BV5 1, 5 10,
20, and 30 ml/100g were 0.003, 0.017, 0.034, 0.068, and
0.1, respectively. Simulated relative transverse relaxation
time constants T 2 plotted as functions of fractional blood
oxygen saturation in HNSCC are shown in Fig. 3A. The coef-
ficients A*, B*, and C* for BV5 5 ml/100g were 12.42,
19.58, and 17.5, respectively, and the T 2 Y50 y-intercept value
TABLE 2. Summary of Tumor Characteristics
Pt. No. 18 Vol.
[cc]
LNs Vol.
[cc]
Median T2* [msec]
18 LNs
MRI1 MRI2 D MRI1 MRI2 D
1 12 15 NA NA NA 17.6 20.7 3.1
2 17.8 21 3.2
2 32 3 18.3 18.7 0.4 25.6 26.7 1.1
3 27 2 18.5 18.8 0.3 24.2 23.3 20.9
7 22.9 24.6 1.7
2 17 18.9 1.9
4 29 21.5 21.5 0.01
5 173 6 19.2 17.8 21.4 21.5 20.3 21.1
2 21.5 24 2.5
1 26 26.2 0.2
6 15 16.3 19.7 3.4
7 6 60 18.6 18.5 20.2 26.3 26.2 20.1
8 10 28.4 29.2 0.8
15 24.6 23.9 20.8
9 17 21.7 22.5 0.8
10 45 5 16.81 19.19 2.4 NA NA NA
18: primary tumor, LNs: lymph nodes.
*NA5 insufficient or poor quality data.
FIGURE 2: Bland–Altman plot showing difference between
median VOI T 2 in two scans against the mean value of T

2 for
both visits (CR5 coefficient of repeatability, CV5 coefficient of
variation). Mean difference (solid line) and 95% limits of agree-
ment (dotted lines) are also shown, with corresponding 95%
confidence limits (error bars).
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was 19.4 msec. The relative T 2 dependence plot for
BV5 5 ml/100g with LoA is illustrated in Fig. 3B. A blood
oxygen partial pressure of 20 mmHg corresponded to frac-
tional oxygen saturation of Y5 0.32 and was used as a thresh-
old to identify clinically relevant regions of hypoxia in Fig.
3B. The T 2 dependence of fractional oxygen saturation
increases monotonically, resulting in increasing sensitivity of
the method with increasing blood oxygenation. In normoxic
conditions, small changes of DY result in T 2 changes greater
than the repeatability LoA (DT 2 > LoA). For example, an
increase of fractional blood oxygenation from 0.4 to 0.5
would lead to an increase of T 2 of 4.8 msec, with the corre-
sponding repeatability threshold of 1.9 msec (LoA5 13%).
T 2 value differences were lower than the measurement repeat-
ability for fractional blood oxygen saturation below 0.11, or
pO2 of 12.4 mmHg. For Y values above that threshold,
changes in T 2 were sufficient to detect differences in blood
oxygenation greater than 10% (DT 2 >LoA for DY> 0.1).
Discussion
MRI measurements of transverse relaxation times have the
potential to characterize tissue oxygenation and therefore are
of interest in the context of tumor hypoxia imaging. Never-
theless, quantitative tissue oxygenation measurements using
BOLD MRI remain a challenge due to T 2 dependence on
additional biological and physicochemical factors, together
with significant intra- and intertumor variations. These con-
comitant independent parameters are likely to explain the
moderate correlation between T 2 , direct measurement of
tumor tissue oxygen tension, and immunohistochemical
detection of pimonidazole. It is therefore desirable to
directly measure these nonoxygen-related contributions and
FIGURE 3: A: Transverse relaxation time constant T 2 simulated for blood volume fractions in the range 1–30mL/100g plotted as a
function of blood O2 saturation (hematocrit: 0.4, microcapillary vascular factor 0.85, field strength: 3T). B: Relative T

2 dependence
of fractional blood oxygenation and pO2 simulated for BV55mL/100g. The dashed line shows limits of agreement (LoA,
a50.05). The oxygen partial pressure was calculated using Hill’s equation (human blood, coefficient for blood oxygen binding:
2.26, temperature: 378C, pH: 7.4).
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to stratify tumors into more homogenous subgroups
depending on disease site, level of edema, necrosis, and per-
fusion. Several methods for BV calculation using MRI have
been proposed, including measurements of changes in T 2
induced by injection of paramagnetic contrast agents such as
ultrasmall superparamagnetic iron oxide (USPIO) particles33
and gadolinium chelates (dynamic susceptibility contrast
[DSC] MRI34). To date, USPIO has been investigated clini-
cally as an off-label intravenous MRI contrast agent with
various imaging applications35 and could be used in the
context of BV measurements. It is also possible to use T 2 to
study changes in tissue oxygenation as a result of an acute
intervention such as blood transfusion, vascular disruptive
therapy, or hyperoxic gas challenge, where the significance
of relative T 2 changes rather than absolute oxygenation lev-
els is of interest.
It is important to recognize that the sensitivity of the
quantitative determination of tissue T 2 is strongly depend-
ent on measurement repeatability, which in turn is influ-
enced by the iterative shimming process employed. Our
data show that a minimum change in median tissue T 2 of
13% is required to be regarded as statistically significant
within an individual primary tumor or metastatic lymph
node. In general, primary HNSCC tumors are expected to
be affected by motion and shimming imperfections associ-
ated with tissue/air interfaces, and which can explain the
increased differences seen in the lower T 2 regions. Our
model simulation of tissue T 2 shows that the sensitivity of
the measured change in T 2 increases as a function of frac-
tional blood oxygenation. For HNSCC tumors, measured
oxygen partial pressure vary widely across a range of 0–
70 mmHg, but with a median of between 10 and
20 mmHg.36,37 The measured sensitivity of median tumor
tissue T 2 is thus sufficient to permit detection of clinically
significant changes in tumor tissue oxygenation for most
HNSCC tumors. However, an exception exists for anoxic,
and severely hypoxic, tumor regions (Y< 0.11), where the
T 2 value differences are lower than the measurement repeat-
ability (LoA5 13%).
Several limitations of our study must be considered.
First, BOLD measurements are mainly sensitive to the vas-
cular space and therefore are not suitable for assessment of
tissue oxygenation in the absence of functional erythrocyte
perfused blood vessels, such as within necrotic tumor cores,
which may often be present within metastatic H&N lymph
nodes. In addition, there is uncertainty with regard to the
appropriate value for the vascular factor (fvas) used in the
quadratic model of T 2 dependence on fractional blood oxy-
genation.24,26 Second, the measured T 2 repeatability disre-
gards the presence of true physiological fluctuations in
blood flow within the tumor capillary network that lead to
transient or cyclical hypoxia, which has been reported in a
number of studies.16,38 It should be noted that the repeat-
ability of any quantitative MRI biomarker might be influ-
enced by a number of methodological factors, such as
patient setup, VOI localization, sequence parameters, and
shimming method. In terms of this study, the extent of
superior–inferior anatomical coverage used was relatively
small (<6 cm), and therefore local shimming is expected to
be more repeatable in comparison to large field of view
studies in other anatomical sites.39 Another limitation of the
study was the relatively small number and heterogeneity of
tumors imaged (8 primary and 14 metastatic nodal VOIs),
with the majority localized in the oropharynx. The distribu-
tion of T 2 for all patient VOIs, however, was distributed
normally, allowing for a reliable repeatability analysis. The
accuracy of measured T 2 values can also depend on the
choice of echo times and type of data processing. In general,
the signal-to-noise ratio (SNR) in the VOI should be
adequate for images acquired using all echo times.27 Tissues
characterized by short transverse relaxation times suffer from
low SNR in the longer echo time images, which may lead
to a subsequent overestimation of T 2 . These effects are not
likely to significantly affect the relatively long mean T 2 val-
ues measured at 3T in HNSCC nodal and primary tumor
sites (23.6 and 18.7 msec, respectively). The noise bias
should not be neglected when calculating relaxation times of
tissues with short T 2 , or in the case of subregional voxel-
based analysis, in which case Bayesian or data truncation
methods might be required.27 The number of echoes used
herein was a result of using in-phase fat and water signal
with echoes acquired with the same gradient polarity,
together with SNR threshold. Previous clinical T 2 studies
have employed between 4 and 16 echo times.19,39,40 In this
study, the signal acquired with the gradient echo sequence
was found to be dominated by noise for echo times longer
than 30 msec. In-phase fat and water echo times were cho-
sen to account for variable fat content in H&N tumors
resulting in potential signal cancellation effects.
Simulations highlight the necessity of additional meas-
urements to enable interpretation of T 2 data and quantita-
tive measurements of tissue oxygenation using BOLD
imaging, such as blood volume fraction and macroscopic
field homogeneity affecting measurement repeatability.
Future investigations of T 2 as an imaging hypoxia bio-
marker should include these confounding factors and would
benefit from a direct histological verification, which was not
available in this study.
The median T 2 values measured in the primary
tumors were significantly lower than in metastatic lymph
nodes, which is likely a consequence of a higher blood vol-
ume rather than more severe hypoxia. Similarly, interpreta-
tion of lower T 2 tumor subregions is possible if the spatial
distribution of blood volume is known. The information on
tissue oxygenation could be used to assist treatment manage-
ment, enabling the identification of radioresistant tumors,
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for which radiotherapy dose escalation, radical surgery, or
targeted chemotherapy could be used as an alternative or a
supplement of a conventional treatment.
In conclusion, our results confirm the utility of quan-
titative measurements of T 2 at 3T to detect clinically rele-
vant tumor tissue oxygenation across a wide range of BV
and oxygen tensions, including those reported for HNSCC.
This establishes tumor tissue T 2 measurement as a sensitive
and reproducible quantitative imaging technique that may
be used in future studies of tumor hypoxia.
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